Clinical Trials Directory

Trials / Unknown

UnknownNCT02659228

Assessing Covert Consciousness in Unresponsive Patients

Assessing the Potential for 'Covert Consciousness' in Unresponsive Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

In this study, the investigators explore anesthesia as a tool for providing further insight into the level of consciousness of individuals with a clinical diagnosis of unresponsive wakefulness syndrome (UWS), but who possess some neurophysiological signatures of conscious awareness. This group, who could potentially be conscious, will herein be referred to as the target population. Our goal is to assess whether or not neurological patterns of consciousness in the target population respond to anesthesia in a similar manner to neurologically compromised individuals with known consciousness (e.g. those in minimally conscious state (MCS). In healthy controls, propofol-induced unconsciousness results in an elimination of the mismatch negativity event-related brain potential (ERP) and a diminished directed connectivity. The investigators hypothesize that at doses well below those required for surgery, anesthesia will have similar effects on these neural patterns in neurologically compromised patients with the potential for conscious awareness, but will not affect these patterns in those who lack consciousness.

Conditions

Interventions

TypeNameDescription
DEVICEEEG recordingEEG recording with anesthetic (DIPRIVAN)
DRUGAnesthetics, IntravenousThe participant will receive an intravenous infusion of propofol (DIPRIVAN Injectable Emulsion USP 1%, AstraZeneca).

Timeline

Start date
2016-12-01
Primary completion
2017-06-01
First posted
2016-01-20
Last updated
2016-10-27

Source: ClinicalTrials.gov record NCT02659228. Inclusion in this directory is not an endorsement.